17.65
1.50%
+0.26
After Hours:
17.65
Electromed Inc. stock is currently priced at $17.65, with a 24-hour trading volume of 46,517.
It has seen a +1.50% increased in the last 24 hours and a +8.82% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $16.87 pivot point. If it approaches the $17.91 resistance level, significant changes may occur.
Previous Close:
$17.39
Open:
$17.4
24h Volume:
46,517
Market Cap:
$151.88M
Revenue:
$51.69M
Net Income/Loss:
$3.94M
P/E Ratio:
49.03
EPS:
0.36
Net Cash Flow:
$3.65M
1W Performance:
+5.50%
1M Performance:
+8.82%
6M Performance:
+68.74%
1Y Performance:
+69.55%
Electromed Inc. Stock (ELMD) Company Profile
Name
Electromed Inc.
Sector
Industry
Phone
952-758-9299
Address
500 Sixth Avenue NW, New Prague, MN
Electromed Inc. Stock (ELMD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-18-19 | Initiated | Dougherty & Company | Buy |
Dec-31-13 | Reiterated | Feltl & Co. | Buy |
Oct-19-10 | Initiated | Feltl & Co. | Buy |
Electromed Inc. Stock (ELMD) Financials Data
Electromed Inc. (ELMD) Revenue 2024
ELMD reported a revenue (TTM) of $51.69 million for the quarter ending December 31, 2023, a +18.03% rise year-over-year.
Electromed Inc. (ELMD) Net Income 2024
ELMD net income (TTM) was $3.94 million for the quarter ending December 31, 2023, a +88.73% increase year-over-year.
Electromed Inc. (ELMD) Cash Flow 2024
ELMD recorded a free cash flow (TTM) of $3.65 million for the quarter ending December 31, 2023, a +242.03% increase year-over-year.
Electromed Inc. (ELMD) Earnings per Share 2024
ELMD earnings per share (TTM) was $0.45 for the quarter ending December 31, 2023, a +95.65% growth year-over-year.
About Electromed Inc.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Cap:
|
Volume (24h):